TY  - CHAP
AU  - Vivek Kaushik
AU  - Juan Sebastian Yakisich
AU  - Yogesh Kulkarni
AU  - Neelam
Azad
AU  - Anand Krishnan V. Iyer
ED  - Alba Fabiola Costa Torres
Y1  - 2018-10-31
PY  - 2018
T1  - Chemoresistance of Lung Cancer Cells: 2D and 3D In Vitro Models for Anticancer Drug Screening
N2  - Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer.
BT  - Lung Cancer
SP  - Ch. 9
UR  - https://doi.org/10.5772/intechopen.78946
DO  - 10.5772/intechopen.78946
SN  - 978-1-78984-350-7
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-27
ER  -